Condensed Consolidated Balance Sheets (unaudited) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Current Assets:
Cash and cash equivalents	$ 2,433.6	$ 617.9
Accounts receivable, less allowance for doubtful accounts	1,039.1	1,363.9
Inventories	2,463.2	2,385.0
Prepaid expenses and other current assets	435.0	357.1
Total Current Assets	6,370.9	4,723.9
Property, plant and equipment, net	2,065.5	2,077.4
Goodwill	8,951.2	9,599.7
Intangible assets, net	7,077.7	7,257.6
Other assets	1,047.6	980.1
Total Assets	25,512.9	24,638.7
Current Liabilities:
Accounts payable	404.9	400.9
Income taxes payable	92.9	126.7
Salaries, wages and benefits	181.9	314.1
Other current liabilities	1,149.9	1,099.8
Current portion of long-term debt	1,950.0	1,500.0
Total Current Liabilities	3,779.6	3,441.5
Deferred income taxes, net	857.6	840.1
Long-term income tax payable	688.7	685.1
Other long-term liabilities	580.1	557.8
Long-term debt	7,724.2	6,721.4
Total Liabilities	13,630.2	12,245.9
Commitments and Contingencies (Note 16)
Stockholders' Equity:
Common stock, $0.01 par value, one billion shares authorized, 310.6 million shares in 2020 (309.9 million in 2019) issued	3.1	3.1
Paid-in capital	8,984.3	8,920.1
Retained earnings	9,866.2	10,427.3
Accumulated other comprehensive loss	(255.1)	(241.9)
Treasury stock, 103.8 million shares in 2020 (103.9 million shares in 2019)	(6,719.9)	(6,720.5)
Total Zimmer Biomet Holdings, Inc. stockholders' equity	11,878.6	12,388.1
Noncontrolling interest	4.1	4.7
Total Stockholders' Equity	11,882.7	12,392.8
Total Liabilities and Stockholders' Equity	$ 25,512.9	$ 24,638.7